Concepedia

Peck Gee Seah

PG

Statistics

Publications

7

Citations

430

H-Index

7

Active since

2011

Affiliations

Novartis (Singapore)(Current)

Novartis (Switzerland)

Novartis (United States)

Experimental Drug Development Centre

Agency for Science, Technology and Research

Peck Gee Seah is an author at Novartis (Singapore) specializing in pharmacology, drug discovery, and antiviral pharmacology.

Publications per year

2011–2020

7

Publications

7

Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis

Srinivasa P. S. Rao, Suresh B. Lakshminarayana, Ravinder Reddy Kondreddi et al. · Science Translational Medicine · 2013 · 149 citations

, , +16

Discovery of Dengue Virus NS4B Inhibitors

Qing-Yin Wang, Hongping Dong, Bin Zou et al. · Journal of Virology · 2015 · 103 citations · Full text

, , +17

Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors

Bin Zou, Wai Ling Chan, Mei Ding et al. · ACS Medicinal Chemistry Letters · 2015 · 72 citations

, , +17

Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580

Yilong Fu, Andy M. Yip, Peck Gee Seah et al. · Antiviral Research · 2014 · 43 citations

, , +14

A Cyclic Phosphoramidate Prodrug of 2′-Deoxy-2′-Fluoro-2′- <i>C</i> -Methylguanosine for the Treatment of Dengue Virus Infection

Ratna Karuna, Fumiaki Yokokawa, Keshi Wang et al. · Antimicrobial Agents and Chemotherapy · 2020 · 29 citations · Full text

, , +16

1–5 of 7